US$ 24.59
glp 1 vs sglt2 Disparities in Inhibitor or Glucagon-Like Peptide Receptor Agonist Initiation Among Medicare-Insured Adults With CKD in the United States Frontiers | Effects of SGLT2
Description
Yes, same-day switching is possible and commonly practiced

K., Osler, M., Jrgensen, M

dapagliflozin: 6929 [12.4%]

MariTide also demonstrated improvements in cardiometabolic risk factors, including reductions in blood pressure and lipid levels

Although some authors claim that DPP4 inhibitors are only beneficial in early stages of diabetes, this could be rebutted by the work of Kumar and Gupta (107)
